Info

Psychedelics Today

Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.
RSS Feed Subscribe in Apple Podcasts
Psychedelics Today
2024
November
October
September
August
July
June
May
April
March
February
January


2023
December
November
October
September
August
July
June
May
April
March
February
January


2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May


Categories

All Episodes
Archives
Categories
Now displaying: 2023
Jul 14, 2023

In this episode, David interviews Dr. Rosalind Watts: famed clinical psychologist, former clinical lead on Imperial College London’s first Psilocybin for Depression trial, and Founder of ACER Integration. 

She discusses the awakening she had after having a child; her work at Imperial College and realizing the importance of staying in touch with patients; the challenges of balancing her work with being a mother; her ACER integration model and the interconnectedness of trees in a forest; how the Watts Connectedness Scale works (and David fills it out); and how much the outside-the-hype surrounding pieces matter – the therapy, the therapeutic relationship, the lessons learned, and the work done to integrate it all. 

And she talks about another moment of awakening, at last year's Psych Summit conference, where capitalism's obsession with profit-over-care frameworks and "magic bullet" and "brain reset" narratives was on full display, which fully enforced what she hopes for in the future: a world where we embrace non-clinical, ceremonial, and nature-based practices; with healing centers (psychedelic and non); supportive communities; infrastructure around conflict resolution and restorative justice; and a shift towards collectivism and collaboration – and how that all starts by finding our psychedelic elders. 

Click here to head to the show notes page!

Jul 11, 2023

In this episode, Joe interviews Oliver Carlin, Founder of Curative Mushrooms, a grow kit solution company designed to produce mushrooms of one’s choosing within 30 days with little effort and no growing experience. 

Carlin tells his personal story of 20 years in the Navy to a 7g psilocybin journey and the work of perfecting these grow bags; how a grow bag works; how easy it can be to grow your own mushrooms; the advantages of growing your own mushrooms vs. buying them; the legalities of grow kits and how he has been able to do this; steps growers can take to reduce their legal risks; the variety of people benefitting from mushrooms (especially in the veteran community); and how growing your own mushrooms seems to make the experience more curated and special.

Curative Mushrooms recently hired someone to create new strains for them every month, they do bimonthly live Q&As for people interested in growing, and they ship a bonus mycology book with each kit that shows how to study spores. They offer growing kits for Lion’s Mane, Turkey Tail, and Shiitake mushrooms, but his most popular option is the “All-in-One Happy Mushrooms for Sad People” kit.

Click here to go to the show notes page

Jul 7, 2023

In this episode, David interviews Dr. Roberta Murphy: member of the Imperial Centre for Psychedelic Research and training medical psychotherapist.

This is a rare impromptu podcast, recorded about a half hour after David heard Murphy speaking on a panel at UK’s Breaking Convention conference. He asked her if she wanted to be on the podcast sometime, and before they knew it, they were recording. Fastest turnaround ever?

She discusses her past research and what she's doing at Imperial College; her work on a psilocybin for depression trial; a psilocybin versus Escitalopram trial; her hopes for psychedelics treating people with Parkinson's; and her recent co-written paper on the ARC Framework (Access, Reciprocity and Conduct), where she will be focusing strongly on the Conduct aspect through her work at Imperial. 

She mostly talks about her other recent paper exploring the impact of one of the more important aspects of therapy: the therapeutic alliance on the psychedelic experience. How does the treatment dynamic between the therapist and the client impact the outcome (and course) of the therapy, and what determines whether it's neutral, negative, positive, or very positive?

Click here to head to the show notes page.

 

Jul 4, 2023

In this episode, Alexa interviews Rachel Clark: Education Manager for DanceSafe, a public health nonprofit specializing in serving people who use drugs and their communities.

As we move into the prime festival season, more people are going to be doing drugs, and the importance of harm reduction and drug testing becomes even more central to the experience. She discusses the complications of drug testing and how it’s more of an act of ruling substances out rather than determining purity; the fentanyl problem and its surrounding myths; how to identify and treat an overdose (and what not to do); Philadelphia’s struggles with Xylazine highlighting the problem with regional cross contamination; and DanceSafe’s “We Love Consent” and “Healing is Power” campaigns, which aim to open up the dialogue of true harm reduction and safe spaces outside of the substance alone.

Check out DanceSafe.org for more info, and use this link when you’re ready to make a purchase!

psychedelicstoday.com

Jun 30, 2023

In this episode of Psychedelics Weekly, Joe and Alexa reminisce about last week's Psychedelic Science 2023, dubbed as the largest psychedelic conference in history. 

They discuss Joe's two Psychedelic Morning Shows with Anne Philippi; Court Wing, Bob Wold, and the work of Clusterbusters and the new Psychedelics and Pain Association; Aaron Rogers and athletes' growing interest in psychedelics; the legality of mushroom growing kits; and the overall fun and overwhelming atmosphere of such a massive event. And as Alexa had her first breathwork session with the East Institute, they dig more into breathwork, which serves as somewhat of a follow-up to our breathwork episode a few weeks ago.  

They also talk about a short film they came across called "Open Up," which looks at the party lifestyle of always seeking a new high, the potential of ketamine abuse, and what can happen when people don't talk about their problems.

https://psychedelicstoday.com/2023/06/30/psychedelics-weekly-a-recap-of-psychedelic-science-2023/

Jun 27, 2023

In this episode, David interviews Professor Celia Morgan, Ph.D., who holds the Chair of Psychopharmacology and co-leads the Transdisciplinary Psychedelics Group at The University of Exeter.

This was recorded on the dawn of UK's Breaking Convention conference, where Morgan was speaking about the therapeutic potential of ketamine as well as the danger of people developing a dependence on it. She touches on that topic, but largely discusses her current Phase III Trial for ketamine-assisted therapy for the treatment of severe alcohol use disorder (also called the KARE model (Ketamine for reduction of Alcohol Relapse)), a collaboration with Awakn Life Sciences.

She discusses her other research: studies on mindfulness intervention before and after ketamine, epigenetic changes after ayahuasca use, the antidepressant qualities of ayahuasca, and CBD for cannabis dependence. And she talks about the necessary balance for making treatments amazing but affordable; how connecting with nature during integration is key; how the drug is just a tool, yet we focus on it too much; and how we need studies on how different therapies work with different substances.

www.psychedelicstoday.com

Jun 23, 2023

In the second episode of our special, two-part series, the Psychedelic Morning Show, Joe Moore and Anne Philippi are live once again bright and early from Psychedelic Science 2023 in Denver.

Listen to this podcast as they interview four guests working on the front lines of psychedelic research, law, and the treatment of chronic pain. 

Guests for this episode include: 

  • Tommaso Barba – PhD candidate at Centre for Psychedelic Research, Imperial College London
  • Allison Hoots – Attorney at Hoots Law Practice and advocate; President of Sacred Plant Alliance
  • Bob Wold - Founder & President, Clusterbusters
  • Court Wing – Founder, REMAP Therapeutics 

psychedelicstoday.com

Jun 23, 2023
Psychedelics Today is reporting live this week from the industry event of the year, Psychedelic Science 2023 in Denver. Listen in to this podcast as our co-founder, Joe Moore, and New Health Club founder Anne Philippi hit the conference floor bright and early in the first episode of a special two-part series, the Psychedelic Morning Show.

In this limited series, Joe and Anne chat in real-time with guests working in all corners of the psychedelic ecosystem, from advocacy, law and finance, to research and therapy. 

Guests for this episode include: 

  • Dr. Julie HollandPsychiatrist, psychedelic researcher, author and medical advisor for MAPS
  • Daniel GoldbergCo-Founder and Principal at Bridge Investments & Palo Santo
  • Hadas AltermanDirector of Government Affairs | American Psychedelic Practitioners Association
  • Melissa LavasaniFounder and Chief Executive Officer at Psychedelic Medicine Coalition, Founder and President of Psychedelic Medicine PAC
  • Tracey TeeFounder of Moms on Mushrooms

psychedelicstoday.com

Jun 20, 2023

In this episode, David interviews Frederick Barrett, Ph.D.: cognitive neuroscientist, Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine, and now, Director of the Johns Hopkins Center for Psychedelic & Consciousness Research.

With today’s news, Barrett officially takes over for the legendary Roland Griffiths, who has been in the role since the Center’s launch in 2019, and who will continue on as a member of the leadership team while dealing with the Stage 4 cancer diagnosis he has been remarkably candid about in recent interviews. 

Dr. Barrett has been conducting research at Johns Hopkins for a decade, authoring or co-authoring some of the first studies on psilocybin’s enduring effects, and receiving the first federally funded human psychedelic research grant from the NIH since the 70s. He discusses the work and importance of Roland Griffiths; the history of the Center and current research he’s most excited about; the mystery of consciousness; and the power and sacredness of music: how we all use music to regulate our emotions, and how he wants to explore the brain mechanisms behind that connection.

www.psychedelicstoday.com

Jun 16, 2023

In this edition of Psychedelics Weekly, Joe and Kyle dedicate the entire episode to one of their biggest passions: breathwork and the power of breath in reaching non-ordinary states of consciousness.

What many listeners may not know is that Psychedelics Today was created because of the lack of attention being paid to breathwork, transpersonal psychology, and the work of Stanislav Grof, so this episode serves as a deep dive into all the facets of our fascinating ability to reach psychedelic states simply by breathing in specific ways.

They discuss the history of breathwork; the various methods (box breathing, alternate nostril breathing, rebirthing breathwork, the Wim Hof method, Holotropic and Transpersonal breathwork, etc.); early and most powerful experiences; why Joe recommends becoming familiar with breathwork before a first psychedelic experience; how a breathwork practice can help enhance psychedelic experiences; and one of the most amazing things about breathwork: that it can give people a sense of agency they may never have felt before – that they can produce these experiences and insights with nothing but their own bodies.

If you've been curious about breathwork, this episode is a great starting point to learn more. 

www.psychedelicstoday.com

Jun 13, 2023

In this episode, Kyle interviews Liana Gillooly: Strategic Initiatives Officer at MAPS, Board Chair & Founder of the non-profit, North Star, and Advisor to Chacruna’s Indigenous Reciprocity Initiative.

While she talks about updates in MAPS’ world and how to manage and scale a rapidly growing industry while trying to change a system from the inside, she mostly talks about what she, the rest of MAPS, and a lot of the psychedelic space in general are most excited about right now: Psychedelic Science 2023, the largest psychedelic conference in history, beginning next week in Denver. 

She discusses the growth of the conference; why they chose Denver as a location; and how programming has changed over the years to embrace the multiplicity of identities inside the psychedelic space, including much more business content, a culture stage that focuses on how psychedelics interact with the mainstream, various programs put on by community partners, pre- and post- workshops covering an array of topics, and an area they’re calling Deep Space, which was designed to help attendees get out of their heads and more into their bodies. 

If you were thinking of attending, this episode should serve as a great inspiration to finally buy a ticket. When you do, be sure to use code PT15 to get 15% off your purchase, and when you’re there, visit us at booth 834 Wednesday through Friday. Joe is hosting a Psychedelic Morning Show with Anne Philippi on Thursday and Friday, and we’re partnering with Lounge CashoM, an all-inclusive environment designed to be a decompression space from that big conference energy. Email hello@cashom.org for more info, and head to the show notes page for more details about afterparties.

www.psychedelicstoday.com

Jun 6, 2023

In this episode, David interviews Alex Belser, Ph.D.: clinical scientist; author; licensed psychologist; Co-Investigator for a psilocybin and OCD study at Yale University; and co-creator of the EMBARK approach, a new model of psychedelic-assisted therapy that focuses on six clinical domains that typically arise during psychedelic experiences.

He is also one of the editors of "Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine," the new anthology from Chacruna featuring 38 essays from queer authors and allies looking at the heteronormative aspects of psychedelic culture and psychedelic-assisted psychotherapy, self-acceptance, psychedelics and pleasure, and ways the queer community can become allies with other groups. As they serendipitously recorded this episode on June 1, it only made sense to celebrate Pride Month by releasing it now, as well as launching a giveaway, where you can win one of five copies of "Queering Psychedelics." 

Belser talks about the concurrent emergence of the psychedelic and queer communities; the need to research the effects of transphobia and homophobia in psychedelic work (as well as the internalized phobias often realized during an experience); why it’s more important than ever to talk about the psychedelic space’s dark past with conversion therapy; why the Mystical Experiences Questionnaire needs to be updated; the idea of queer people being boundary walkers; recreating the Good Friday Experiment, the immense importance of long-form interviews and other forms of qualitative research, the power of love and community, and the question: how does anyone not want to change after a powerful psychedelic experience?

www.psychedelicstoday.com

Jun 2, 2023

In this episode of Psychedelics Weekly, Joe and Kyle are once again able to take advantage of Kyle's temporary Colorado residency and record together in Joe's office.

While last week focused on the numerous challenges facing a rapidly growing industry of psychedelic therapists, facilitators, and guides, the topic of therapy itself is put under the microscope this week, as they dissect a New York Times article titled, "Does Therapy Really Work? Let’s Unpack That." They discuss whether or not therapy is right for everyone, the efficacy of different types of therapy, the role of the therapeutic alliance in treatment outcomes, and how (if it's even possible) to measure all of these factors.

They also discuss:

-a study showing that ketamine was more effective than ECT (electroconvulsive therapy) for patients with treatment-resistant depression;

-the potential benefits of the LSD analog, Br-LSD, in treating people with major depressive disorders, cluster headaches, and more;

-Ireland's Health Service Executive launching the Safer Nightlife program, which will partner with music festivals this summer to establish on-site drug testing;

-the U.S. slowly beginning to legalize fentanyl test strips, which, for some reason, are illegal in many parts of the country;

And much more!

See you next week, and if you're in the NYC area, make sure to check out "Tales of Transformation," an in-person event Thursday, June 8 at the Athenæum, moderated by David, and featuring Ifetayo Harvey, Juliana Mulligan, and Raad Seraj.

www.psychedelicstoday.com

May 30, 2023

In this episode, Joe interviews the Co-Founders of Enosis Therapeutics: researcher and scientist, Agnieszka Sekula; and psychiatrist, clinical advisor to the Australian Psychedelic Society, and leading Australian advocate for psychedelic-assisted psychotherapy, Dr. Prash P. 

Enosis Therapeutics is a medtech startup that began with the question: how can we use VR – with or without psychedelics – to improve mental health outcomes? They feel that the biggest problem with powerful psychedelic experiences is that, once you’re back in reality, it’s oddly difficult to remember the insights and new ideas that were so clear during the experience, and even harder to make connections that lead to concrete change. They believe that the immersive nature of VR and the novelty of unique VR environments creates a sense of presence that can’t be recreated otherwise – a liminal, in-between state that’s just different enough to allow the patient to feel like they’re back in that non-ordinary state, and therefore more able to anchor their experience and begin to find connections and more clearly understand newfound insights. 

This all happens by the user essentially creating nonlinear, abstract, multi-sensory VR paintings while describing what they remembered; allowing them to revisit these worlds later, bring in therapists (or anyone else) to work inside these environments, and hear their own voice describing what happened, thereby creating a mental map that can be worked with in completely unique ways. 

They talk about the conflict between new technologies and traditionalists; the problems with moving away from psychoanalysis and not treating psychotherapy as a process; how VR could improve the efficacy of therapy (and improve therapists’ lives); how it could replace models of repeated dosage; how VR could generate analytics to actually quantify success in mental health treatment; and how (whether psychedelics are used or not) culture needs to bring the psychedelic way of thinking to mental health.

www.psychedelicstoday.com

May 26, 2023

In this episode of Psychedelics Weekly, Kyle and David meet up to talk news, but end up mostly having a discussion about the numerous challenges facing the rapidly growing industry of psychedelic therapists, guides, and facilitators.

That discussion comes from the article, “Psychedelic workers of the world, unite!”, which breaks down the shortcomings and risks of an industry many are flocking to without realizing what they’ll likely have to deal with: unprecedented legal and financial risks, burnout, misalignment with management, transference and countertransference, and what happens when one finds themselves in the middle of a genuine emergency? While these issues could be found in any industry, a big reason why they seem so prevalent and dangerous in the psychedelic world is our lack of elders and passed-down experience – and the faster this all grows, the more we need that guidance. 

And for news, they talk about Ohio State making history as the first U.S. University to receive a license to grow psilocybin mushrooms; a new study showing that LSD enhanced learning, exploratory thinking, and sensitivity to feedback; and the National Institute on Drug Abuse (NIDA) funding $1.5 million to research the efficacy of psychedelics for substance use disorder – which spurs a conversation about research, funding, and the idea that maybe we’re spending too much time and money on neuroscience.

www.psychedelicstoday.com

May 23, 2023

In this episode, Joe interviews Priyanka Wali, MD: board-certified practicing physician in Internal Medicine, MAPS-trained psychedelic facilitator, comedian, and co-host (with Sean Hayes of "Will & Grace" fame) of the HypochondriActor podcast, where they discuss interesting medical issues in a funny (and hopefully uplifting) way. 

She talks about recognizing and protecting the humanity of healthcare professionals, and how medical school is creating a cycle of hurt people trying to help other hurt people. She believes we need to become more holistic, especially in embracing Indigenous ways of thinking, as their frameworks may be the only way to explain phenomena with which Western science can’t come to terms.  

They talk a lot about ancient psychedelic use: the use of a soma described in the Rigveda; Egyptian culture and mushrooms observed in statues; Plato; the work of Brian Muraresku and Graham Hancock; and Vedic chants, Kashmiri Bhajans, and how singing (especially in a group) can be especially healing to the nervous system. And as Wali experienced first-hand the Kashmiri Pandit genocide of 1990, she discusses how much colonialism has changed cultures, and how much our cycles of oppression relate to our collective inability to experience pain and fear.  

They discuss the psychological impact of living through major catastrophes; the special and hard-to-describe feeling of returning to your home (especially in a world changed by colonization and constant conflict); the sad case of Ignaz Semmelweis and hand washing; ghosts of Japan’s 2011 tsunami, the concept of ‘future primitive,’ and more.

www.psychedelicstoday.com

May 19, 2023

In this episode of Psychedelics Weekly, Joe and Kyle are both on the road, so David and Alexa take the helm.

They cover news stories about: 

-a man in Colorado facing a Class 3 drug felony for giving people psilocybin mushrooms in exchange for monetary donations – pointing out the bold (or stupid?) stances some are taking to highlight the absurdity of legislation that allows possession and donation as long as no money changes hands; 

-a study showing what many of us have felt ourselves: that the day after psilocybin-assisted therapy, depressed patients had a stronger brain response to music and saw improvements in the ability to find pleasure in previously empty activities; 

-a trip report from a psychedelically-naive 50-year old, showing the power and beauty of MDMA-assisted therapy; 

-the New Hampshire state Senate continuing to be behind the times and voting down House Bill 639, which would have created a legal recreational cannabis framework for the state;

-a video where people on the street in Oregon were asked how much they thought psilocybin therapy would cost, showing a drastic misalignment between public perception and reality;

and a local TV news feature touring Rose City Laboratories, the first licensed psilocybin testing lab in Oregon.

And in conversation, they talk about some of the lesser-discussed (and often dismissed) tools like CBD, THC patches, and very low-dose edibles; the problem with drug dealers and harm reduction; the power of music in guiding a psychedelic experience (and in living a pleasurable life); and the importance of dosing and listening to your body to know what's right for you.

www.psychedelicstoday.com

May 16, 2023

In this episode, Joe interviews Nick Kadysh: Founder and CEO of PharmAla Biotech and member of the board of directors for The Canadian Psychedelic Businesses Association. 

PharmAla Biotech is a Toronto-based Life Sciences company with two focuses: contracting with manufacturers to provide researchers with GMP MDMA (created under Good Manufacturing Practice regulations), and creating and researching novel analogs of MDMA. And just today, they announced that Health Canada has authorized them (and their distribution partner, Shaman Pharma) to supply their LaNeo™ MDMA for the treatment of a patient under Canada’s Special Access Program – the first time this has happened in Canada. 

He discusses the creation of PharmAla and why their model changed from primarily researching analogs to manufacturing; why they’re operating out of Canada and using manufacturers instead of running the lab themselves; the excitement around Australia’s recent about-face on MDMA and psilocybin-assisted therapy; the bureaucracy of U.S. drug policy and how much a broken supply chain affects the whole industry; bad IP and companies filing rapid fire patents; why creating new analogs of MDMA is so important; and why the psychedelic space needs to bring culture along with us.

He also talks about Spravato, cannabis and risks of cancer, THC nasal sprays, and research he’s most excited about: that MDMA seems to alleviate dyskinesia caused from Parkinson’s disease, and that MDMA could improve social anxiety in people with autism. He’s aiming to run a clinical trial and believes they have developed a safe MDMA analog that the autistic community will respond to very well.

www.psychedelicstoday.com

May 12, 2023

In this episode of Psychedelics Weekly, Joe and temporary-Colorado-resident Kyle once again record in-person, discussing how psychedelics could change business, the drug war and safe supply, and more. 

They cover: 

-a Rolling Stone profile on David Bronner, who makes the case for multi-stakeholder capitalism; where businesses are accountable to their workers, customers, the environment, and surrounding Indigenous communities instead of just investors – an idea more people would likely align with after a psychedelic experience; 

-The first psilocybin service center in Oregon (EPIC Healing Eugene) finally receiving their license via the Oregon Health Authority;

-A man who saw his color blindness improve for four months after a 5g mushroom experience;

-Delaware officially legalizing recreational cannabis; 

-The opening of 'The Drugs Store' in Vancouver, British Columbia: a mobile store selling drugs illegally as a response to the opioid epidemic and constant influx of untested and laced drugs – the "inevitable result of the government doing nothing" towards offering a safe supply; 

-and a survey from the CDC showing that cannabis use among teenagers has declined since legal dispensaries began opening, disproving one of the most common prohibitionist arguments that legalization would only increase use. 

And of course, these topics bring on a lot of conversation: how businesses need to be more reflective on how they're operating; concern over if too much regulation is nerfing the world; the human cost of the drug war and the ever-escalating amount of ODs and drug poisoning cases; HPPD and the need for research around psychedelics and vision/perception; why we will always need both clinical access and the recreational underground, and more.

www.psychedelicstoday.com

May 9, 2023

In this episode, Joe interviews Erica Rex: award-winning journalist, past guest and writer, and participant in one of the first ever clinical trials using psilocybin to treat cancer-related depression; and Mona Sobhani, Ph.D.: cognitive neuroscientist and the author of "Proof of Spiritual Phenomena: A Neuroscientist’s Discovery of the Ineffable Mysteries of the Universe."

As Rex discovered the power of psychedelics through a clinical trial, she discusses a huge problem she discovered: that researchers are not preparing participants enough for the ontological shock they may go through in trying to match unexplainable happenings to a rigid framework (or match the normal to a framework that has suddenly shifted) – that while patients have support at the clinic, it all disappears when they return to normal life. She believes that all too often, researchers are doing only what is necessary to be able to continue to receive funding, push drugs through the FDA, and prescribe a pill. 

And as psychedelics changed Sobhani from very constrained scientific thinking to being very open to new ideas about consciousness and spirituality, she learned that many scientists had similar stories, and that coming out of the psychedelic closet is sometimes the best thing to do to normalize these ways of healing. 

They discuss the challenges of newcomers trying to explain their experience without having the necessary language; how we still don't truly understand mental illness; how the DSM just clusters symptoms to fit 'disorders' into a box; how society has started pathologizing anything we find unpleasant (which of course, is a part of being human); Gary Fisher’s research on using LSD and psilocybin for schizophrenic children, why science needs to combine consciousness research and psychedelics research, and more.

www.psychedelicstoday.com

May 5, 2023

In this episode of Psychedelics Weekly, Joe and Kyle record in-person again, discussing psychedelics and parenthood, sports, music, and more. 

They cover:

-an Elle (!) article about how mushrooms are becoming the new ‘Cali sober,’ with more and more people starting to microdose – including parents; 

-ESPN's documentary, "Peace of Mind," highlighting the rise of psychedelic use among athletes, including retired NHL player, Riley Cote;

-An article discussing how interest in psychedelics has skyrocketed in Oregon since the passing of Measure 109, and how over-regulation and the glacial speed of the government is only driving the growth of the black market; 

-An essay attempting to define what it is that leads people to describe music as psychedelic (with several recommendations from Joe); 

-DMT aficionados using AI to create and catalog depictions of the entities they've seen;

and more!

And they have larger discussions about the drug war, how famous athletes are opening people's minds to psychedelics, how strict regulation in psychedelic legislation can create more harm, how we need to collaborate more in the psychedelic space, the concept of a DMT 'hyper-slap,' and the problem of psychedelic exceptionalism and thinking your drug is good while others are bad.

www.psychedelicstoday.com

May 2, 2023

In this episode, David interviews two founding members of Fireside Project: activist, healing justice practitioner, musician, and Chief Ambassador, Hanifa Nayo Washington; and lawyer, aspiring researcher, and Executive Director, Joshua White, Esq.

Fireside Project was created after White volunteered for a help line for years and realized a few things: that follow-up calls made a big difference; that the state of mental health in the U.S. was a disaster (he was talking to some of the same people for years); and that while psychedelics were becoming popular, they would likely only be accessible to the wealthy. Alongside Washington, they realized the most effective thing they could do would be creating a free help line where people could call for peer support during a psychedelic experience, and receive support in integrating that experience afterward. They’ve focused on finding volunteers who may be marginalized or who have been persecuted from the war on drugs, but most importantly, have real experience and true compassion (rather than letters after their name proving their credentials). They are on track to receive 10,000 calls over their first two years.

They discuss Fireside’s Burning Man origin story; the serendipity they’ve seen in the organization’s beginnings and so many calls; where the name came from; how they prepare volunteers; what true equity looks like; and how, while it’s a common challenge for therapists and facilitators to hold back and not try to fix a problem, that may be even more important here.

Fireside Project takes calls every day from 11am – 11pm PST, and while there is an app you can download, they recommend saving their number in your phone for when you need it (62-FIRESIDE). And to destroy the notion of being afraid to ask for help, they encourage everyone to share their stories on social media: the times that you’ve used Fireside Project or the times you had a challenging experience and wish you had known about them. Many newcomers have no idea this support exists, and it could truly be life-changing for them.

www.psychedelicstoday.com

Apr 28, 2023

In this episode of Psychedelics Weekly, David speaks with Kyle, who recorded at Joe’s place while he was away at Trailblazers in NYC. 

They talk about David’s trip to the UK last week for Breaking Convention, then discuss a recent Vice article about looking outside the binary and confined thinking of Western medicine and embracing the underground – that there are cheaper and more accessible peer support models and affinity groups for everyone, but in going underground, we need to be careful that more accessible models aren’t dangerous or re-traumatizing. While businesses are competing to make headway in the psychedelic space, nobody is controlling all of it, which leads to both possibility and risk. 

They cover SB23-290, the bill Senate President Steve Fenberg created to establish a regulatory framework for psilocybin access and administration in Colorado in lieu of the advisory board that should have been put in place as part of Prop 122. They break down the positives and negatives of this framework, and ask: how much do these committees who are passing legislation really know about psilocybin? 

And they briefly discuss an article on what MDMA therapy may look like when MAPS hopefully gets approval via the FDA early next year, Rick Doblin’s speech at Breaking Convention, and his concept of society eventually having “net zero trauma.”

www.psychedelicstoday.com

Apr 25, 2023

In this episode, Joe interviews Deborah Parrish Snyder: ecologist, Director and VP of the Institute of Ecotechnics, and Co-owner and CEO of Synergetic Press, which has published over 40 books on ethnobotany, psychedelics, biospherics, and social and ecological justice. 

Straddling the line between ecology, psychedelics, and psyche, she discusses the many projects of the Institute: Biosphere 2, the large-scale closed ecological system she helped design in 1986; London's "October Gallery," a man-made city biome project that could be a model for other cities; their "Eden in Iraq" wastewater project; and the Heraclitus, an 82-foot ship which has sailed 270k miles around the earth, studying different cultures, mapping coral reefs, and more, and will soon be setting sail again after being rebuilt for the last decade.  

She talks about where we're at as a society in regards to the environment: how we're in a period of consequences and it's easy to feel hopeless, but much of the youth are "solutionists" who don't want to hear apologies, and instead, want to do something about it. She believes that while schools don't teach ecology, it's never too late to learn, and non-ordinary states of consciousness could help people remember our connection to nature, care about our planet, and find the others who feel the same way. Consider pairing your self-exploration with improving the world around you: what can you do to turn your perfect, overly fertilized lawn into a regenerative landscape instead?

www.psychedelicstoday.com

Apr 21, 2023

In this episode of Psychedelics Weekly, Joe and Kyle once again record in person, diving into novel compounds, changing opinions, Bicycle Day, and more. 

They start by dissecting a very recent controversy around The Church of Psilomethoxin and whether the sacrament they label as psilomethoxin – supposedly created by adding 5-MeO-DMT to the substrate of cultivated Psilocybe mushrooms – actually contains any psilomethoxin in it. Usona Institute published a paper last week reporting on their analysis of a sample they allegedly collected from the Church, which only showed what we’d see in a sample of a typical psilocybin-containing mushroom. While the Church has issues with Usona’s data collection, analytical methods, and motives, they also reiterate a main component of the church: that their "claims to the existence of Psilomethoxin, at this time, are solely based on faith," and bolstered by their “own direct experiences with the Sacrament.” It’s a very interesting story that touches on faith, consent, personal safety, and the harms of the drug war, which Joe covered extensively in a Twitter Space last night with Andrew Gallimore and the writer of a very critical article, Mario de la Fuente. 

They also discuss: 

-a Time magazine article about the mystery of Long COVID, and how many believe the anti-inflammatory and neuroplastic benefits of psychedelics could be the answer; 

-how Bicycle Day may soon become more popular than 4/20, likely due to society’s warmer reception to the life-changing effects of psychedelics (as opposed to their propagandized and unmoving beliefs about cannabis); 

-how some analysts believe that seven in 10 ketamine companies will likely face financial challenges as the industry grows too quickly; 

and why Snoop Dogg apparently microwaves blunts before smoking them (and does that actually do anything?).

www.psychedelicstoday.com

« Previous 1 2 3 4 5 Next »